<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Liu J</submitter><funding>NINDS NIH HHS</funding><pubmed_abstract>There is a great need for physiologically relevant 3D human cardiac scaffolds for both short-term, the development of drug testing platforms to screen new drugs across different genetic backgrounds, and longer term, the replacement of damaged or non-functional cardiac tissue after injury or infarction. In this study, we have designed and printed a variety of scaffolds for in vitro diagnostics using light based Micro-Continuous Optical Printing (?COP). Human embryonic stem cell-derived cardiomyocyte (hESC-CMs) were directly printed into gelatin hydrogel on glass to determine their viability and ability to align. The incorporation of Green Fluorescent Protein/Calmodulin/M13 Peptide (GCaMP3)-hESC-CMs allowed the ability to continuously monitor calcium transients over time. Normalized fluorescence of GCaMP3-hESCCMs increased by 18 ± 6% and 40 ± 5% when treated with 500 nM and 1 ?M of isoproterenol, respectively. Finally, GCaMP3-hESC-CMs were printed across a customizable 3D printed cantilever-based force system. Along with force tracking by visualizing the displacement of the cantilever, calcium transients could be observed in a non-destructive manner, allowing the samples to be examined over several days. Our ?COP-printed cardiac models presented here can be used as a powerful tool for drug screening and to analyze cardiac tissue maturation.</pubmed_abstract><journal>Bioprinting (Amsterdam, Netherlands)</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6768568</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Rapid 3D bioprinting of in vitro cardiac tissue models using human embryonic stem cell-derived cardiomyocytes.</pubmed_title><pmcid>PMC6768568</pmcid><funding_grant_id>P30 NS047101</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>He J</pubmed_authors><pubmed_authors>Ma X</pubmed_authors><pubmed_authors>Lawrence N</pubmed_authors><pubmed_authors>Zhu W</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Rapid 3D bioprinting of in vitro cardiac tissue models using human embryonic stem cell-derived cardiomyocytes.</name><description>There is a great need for physiologically relevant 3D human cardiac scaffolds for both short-term, the development of drug testing platforms to screen new drugs across different genetic backgrounds, and longer term, the replacement of damaged or non-functional cardiac tissue after injury or infarction. In this study, we have designed and printed a variety of scaffolds for in vitro diagnostics using light based Micro-Continuous Optical Printing (?COP). Human embryonic stem cell-derived cardiomyocyte (hESC-CMs) were directly printed into gelatin hydrogel on glass to determine their viability and ability to align. The incorporation of Green Fluorescent Protein/Calmodulin/M13 Peptide (GCaMP3)-hESC-CMs allowed the ability to continuously monitor calcium transients over time. Normalized fluorescence of GCaMP3-hESCCMs increased by 18 ± 6% and 40 ± 5% when treated with 500 nM and 1 ?M of isoproterenol, respectively. Finally, GCaMP3-hESC-CMs were printed across a customizable 3D printed cantilever-based force system. Along with force tracking by visualizing the displacement of the cantilever, calcium transients could be observed in a non-destructive manner, allowing the samples to be examined over several days. Our ?COP-printed cardiac models presented here can be used as a powerful tool for drug screening and to analyze cardiac tissue maturation.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Mar</publication><modification>2020-10-29T14:22:07Z</modification><creation>2020-05-22T11:28:21Z</creation></dates><accession>S-EPMC6768568</accession><cross_references><pubmed>31572807</pubmed><doi>10.1016/j.bprint.2019.e00040</doi></cross_references></HashMap>